$UTMD SEC Filings

Filed On	Filing
22 Oct 2026	8-K: Results of Operations and Financial Condition Salt Lake City, Utah – Utah Medical Products, Inc. [Nasdaq: UTMD] reports third quarter (3Q) and first nine months (9M) of calendar year 2026 financial results that include changes from the prior year’s same period results.
05 Oct 2026	SCHEDULE TO-I/A
29 Sep 2026	SCHEDULE TO-I/A
25 Sep 2026	SCHEDULE TO-C
24 Sep 2026	SCHEDULE TO-C
24 Sep 2026	SC TO-I
17 Sep 2026	FORM SC TO-C
31 Aug 2026	8-K: Regulation FD Disclosure
14 Aug 2026	SCHEDULE 13G/A
13 Aug 2026	SCHEDULE 13G/A
12 Aug 2026	UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING
23 Jul 2026	8-K: Results of Operations and Financial Condition
01 Jul 2026	Form 4: Richins Paul O, Director Gave 150 shares as a gift ($11K)
29 May 2026	Form 4: Koopman Brian, Principal Financial Officer Gave 50 shares as a gift ($3.31K)
27 May 2026	UTAH MEDICAL FORM SD
14 May 2026	SCHEDULE 13G/A
12 May 2026	UTAH MEDICAL PRODUCTS INC - FORM 10-Q SEC FILING
04 May 2026	8-K: Submission of Matters to a Vote of Security Holders
23 Apr 2026	8-K: Results of Operations and Financial Condition
02 Apr 2026	Proxy statement: annual meeting on May 1, 2026 say-on-pay vote

Comments